Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Profits are valuable, but they’re not everything. At StockStory, we help you identify the companies that have real staying power. Keeping that in mind, here are three profitable companies that don’t make the cut and some better opportunities instead.
Rush Street Interactive (RSI)
Trailing 12-Month GAAP Operating Margin: 7.7%
Specializing in online casino gaming and sports betting, Rush Street Interactive (NYSE: RSI) is an operator of digital gaming platforms.
Why Do We Avoid RSI?
- Lackluster 28.1% annual revenue growth over the last two years indicates the company is losing ground to competitors
- Poor expense management has led to an operating margin of 5.4% that is below the industry average
- Projected 1.2 percentage point decline in its free cash flow margin next year reflects the company’s plans to increase its investments to defend its market position
Rush Street Interactive is trading at $22.47 per share, or 41.4x forward P/E. Read our free research report to see why you should think twice about including RSI in your portfolio.
GATX (GATX)
Trailing 12-Month GAAP Operating Margin: 31.3%
Originally founded to ship beer, GATX (NYSE: GATX) provides leasing and management services for railcars and other transportation assets globally.
Why Does GATX Worry Us?
- Number of active railcars has disappointed over the past two years, indicating weak demand for its offerings
- Negative free cash flow raises questions about the return timeline for its investments
- High net-debt-to-EBITDA ratio of 8× could force the company to raise capital at unfavorable terms if market conditions deteriorate
At $200.81 per share, GATX trades at 19.8x forward P/E. To fully understand why you should be careful with GATX, check out our full research report (it’s free).
Surgery Partners (SGRY)
Trailing 12-Month GAAP Operating Margin: 11.8%
With more than 180 locations across 33 states serving as alternatives to traditional hospital settings, Surgery Partners (NASDAQ: SGRY) operates a national network of outpatient surgical facilities including ambulatory surgery centers and short-stay surgical hospitals.
Why Are We Wary of SGRY?
- Underwhelming unit sales over the past two years imply it may need to invest in improvements to get back on track
- Estimated sales growth of 3% for the next 12 months implies demand will slow from its two-year trend
- 7× net-debt-to-EBITDA ratio shows it’s overleveraged and increases the probability of shareholder dilution if things turn unexpectedly
Surgery Partners’s stock price of $14.32 implies a valuation ratio of 80.4x forward P/E. Dive into our free research report to see why there are better opportunities than SGRY.
Stocks We Like More
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+354% five-year return). Find your next big winner with StockStory today.
